Quarterly report [Sections 13 or 15(d)]

Unaudited Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit)

v3.25.2
Unaudited Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Non-Controlling Interests
Total
Balance at Dec. 31, 2023 $ 3 $ 15 $ 717,396 $ (694,870) $ (20,957) $ 1,587
Balance (in shares) at Dec. 31, 2023 3,427,138 15,093,053        
Stock-based compensation expense     9,856     9,856
Issuance of common stock related to equity plans (in shares)   495,761        
Issuance of common stock under ESPP     51     51
Issuance of common stock under ESPP (in shares)   29,844        
Issuance of common stock for public offering, net   $ 3 10,115     10,118
Issuance of common stock for public offering, net (in shares)   3,303,305        
Issuance of common stock for at-the-market offering, net   $ 2 2,824     2,826
Issuance of common stock for at-the-market offering, net (in shares)   1,554,483        
Common shares issued for dividend on partner company's convertible preferred shares     114     114
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   64,747        
Common shares issued for exchange of partner company's convertible preferred shares   $ 3 3,406     3,409
Common shares issued for exchange of partner company's convertible preferred shares (in shares)   2,028,345        
Warrants issued in conjunction with exchange of partner company's convertible preferred shares     341     341
Preferred A dividends declared and paid     (4,016)     (4,016)
Partner companies' offerings, net     18,002     18,002
Partner company's at-the-market offering, net     1,779     1,779
Issuance of common stock under partner company's ESPP     133     133
Partner company's dividends declared and paid     (352)     (352)
Exercise of warrants for cash     30     30
Exercise of warrants for cash (in shares)   17,500        
Exercise of partner company options and warrants for cash, net     9,370     9,370
Non-controlling interest in partner companies     (29,963)   29,963  
Net loss attributable to non-controlling interest         (41,481) (41,481)
Net income (loss) attributable to common stockholders       (26,365)   (26,365)
Balance at Jun. 30, 2024 $ 3 $ 23 739,086 (721,235) (32,475) (14,598)
Balance (in shares) at Jun. 30, 2024 3,427,138 22,587,038        
Balance at Mar. 31, 2024 $ 3 $ 19 733,290 (710,287) (26,962) (3,937)
Balance (in shares) at Mar. 31, 2024 3,427,138 19,375,343        
Stock-based compensation expense     4,998     4,998
Issuance of common stock related to equity plans (in shares)   34,293        
Issuance of common stock under ESPP     51     51
Issuance of common stock under ESPP (in shares)   29,844        
Issuance of common stock for at-the-market offering, net   $ 1 1,930     1,931
Issuance of common stock for at-the-market offering, net (in shares)   1,092,283        
Common shares issued for dividend on partner company's convertible preferred shares     46     46
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   26,930        
Common shares issued for exchange of partner company's convertible preferred shares   $ 3 3,406     3,409
Common shares issued for exchange of partner company's convertible preferred shares (in shares)   2,028,345        
Warrants issued in conjunction with exchange of partner company's convertible preferred shares     341     341
Preferred A dividends declared and paid     (2,008)     (2,008)
Partner companies' offerings, net     5,265     5,265
Partner company's at-the-market offering, net     295     295
Partner company's dividends declared and paid     (176)     (176)
Partner companies' proceeds from options and warrants, net     4,010     4,010
Non-controlling interest in partner companies     (12,363)   12,363  
Net loss attributable to non-controlling interest         (17,876) (17,876)
Net income (loss) attributable to common stockholders       (10,948)   (10,948)
Balance at Jun. 30, 2024 $ 3 $ 23 739,086 (721,235) (32,475) (14,598)
Balance (in shares) at Jun. 30, 2024 3,427,138 22,587,038        
Balance at Dec. 31, 2024 $ 3 $ 28 763,573 (740,867) (24,381) (1,644)
Balance (in shares) at Dec. 31, 2024 3,427,138 27,908,839        
Stock-based compensation expense     23,082     23,082
Issuance of common stock related to equity plans   $ 1 (1)      
Issuance of common stock related to equity plans (in shares)   1,171,647        
Issuance of common stock under ESPP     43     43
Issuance of common stock under ESPP (in shares)   35,546        
Redemption of partner company preferred shares     (265)     (265)
Issuance of common stock for at-the-market offering, net   $ 1 1,008     1,009
Issuance of common stock for at-the-market offering, net (in shares)   539,563        
Partner companies' offerings, net and warrant exercises     54,094     54,094
Partner company's at-the-market offering, net     6,740     6,740
Issuance of common stock under partner company's ESPP     99     99
Partner company's dividends declared and paid     (332)     (332)
Partner company's exercise of options for cash     240     240
Exercise of warrants for cash     593     593
Exercise of warrants for cash (in shares)   97,200        
Deconsolidation of subsidiary non-controlling interests         (9,931) (9,931)
Non-controlling interest in partner companies     (69,018)   69,018  
Net loss attributable to non-controlling interest         (41,247) (41,247)
Net income (loss) attributable to common stockholders       4,902   4,902
Balance at Jun. 30, 2025 $ 3 $ 30 779,856 (735,965) (6,541) 37,383
Balance (in shares) at Jun. 30, 2025 3,427,138 29,752,795        
Balance at Mar. 31, 2025 $ 3 $ 30 773,668 (751,451) 10,236 32,486
Balance (in shares) at Mar. 31, 2025 3,427,138 29,554,966        
Stock-based compensation expense     16,793     16,793
Issuance of common stock related to equity plans (in shares)   75,083        
Issuance of common stock under ESPP     43     43
Issuance of common stock under ESPP (in shares)   35,546        
Redemption of partner company preferred shares     (115)     (115)
Partner companies' offerings, net and warrant exercises     9,186     9,186
Partner company's dividends declared and paid     (166)     (166)
Partner company's exercise of options for cash     165     165
Exercise of warrants for cash     576     576
Exercise of warrants for cash (in shares)   87,200        
Deconsolidation of subsidiary non-controlling interests         (9,931) (9,931)
Non-controlling interest in partner companies     (20,294)   20,294  
Net loss attributable to non-controlling interest         (27,140) (27,140)
Net income (loss) attributable to common stockholders       15,486   15,486
Balance at Jun. 30, 2025 $ 3 $ 30 $ 779,856 $ (735,965) $ (6,541) $ 37,383
Balance (in shares) at Jun. 30, 2025 3,427,138 29,752,795